80047809 - OncologyConsults: Checkpoint Inhibitors for Treatment of Metastatic Melanoma: Keeping Up with Clinical Advances.



Date & Location
Friday, November 16, 2018, 12:00 AM - Sunday, May 31, 2020, 12:00 AM

Target Audience
Specialties - Nurse Practitioner, Nursing, Oncology, Physician Assistant

Overview
OncologyConsults.com is a learning portal that will address knowledge, competence and clinical practice gaps among clinicians who care for patients with cancers. The metastatic module will be developed for November, 2018 availability, with accreditation availability for one year from posting date. As needed, content will be updated to reflect new guidelines, evidence, and/or best practices, as deemed necessary by the course director and module author.

https://www.oncologyconsults.com/Home/CEData?id=777

Objectives
After participating in this activity, the participant will demonstrate the ability to:

  1. Review the most recent data on checkpoint inhibitors for the treatment of metastatic/unresectable melanoma.
  2. Implement strategies to recognize and manage irAEs in patients receiving checkpoint inhibitors for melanoma.
  3. Develop individualized melanoma treatment plans that appropriately incorporate and dose immunotherapy.

Keywords: ONLINE